Table 5
Prevalence and YLDs, with percentage of total, for anaemia by cause in 1990 and 2013, and prevalence by severity in 2013
| Total prevalence (× 1000) | Total YLDs (× 1000) | Prevalence by severity in 2013 (× 1000) | |||||
|---|---|---|---|---|---|---|---|
| 1990 | 2013 | 1990 | 2013 | Mild | Moderate | Severe | |
| Iron-deficiency anaemia | 1 211 369·9 (66·23%) | 1 208 360·1 (62·57%) | 40 035·5 (64·55%) | 36 612·3 (59·51%) | 607 890·7 (31·48%) | 554 264·6 (28·70%) | 46 204·8 (2·39%) |
| Thalassaemia trait | 75 180·1 (4·11%) | 104 232·6 (5·40%) | 2799·6 (4·51%) | 3769·6 (6·13%) | 39 777·1 (2·06%) | 59 937·8 (3·10%) | 4517·7 (0·23%) |
| Malaria | 57 969·1 (3·17%) | 80 602·4 (4·17%) | 2196·1 (3·54%) | 2935·0 (4·77%) | 32 347·0 (1·67%) | 43 872·2 (2·27%) | 4383·2 (0·23%) |
| Gastritis and duodenitis | 56 836·8 (3·11%) | 63 222·9 (3·27%) | 2092·4 (3·37%) | 2204·4 (3·58%) | 24 768·2 (1·28%) | 35 623·0 (1·84%) | 2831·7 (0·15%) |
| Other neglected tropical diseases | 62 877·1 (3·44%) | 59 728·3 (3·09%) | 2244·9 (3·62%) | 2048·5 (3·33%) | 25 996·2 (1·35%) | 31 016·3 (1·61%) | 2715·8 (0·14%) |
| Other haemoglobinopathies and haemolytic anaemias | 57 242·2 (3·13%) | 55 804·0 (2·89%) | 1566·7 (2·53%) | 1325·5 (2·15%) | 34 620·5 (1·79%) | 19 594·8 (1·01%) | 1588·7 (0·08%) |
| Other infectious diseases | 52 324·3 (2·86%) | 49 771·4 (2·58%) | 1742·5 (2·81%) | 1542·4 (2·51%) | 24 500·4 (1·27%) | 23 327·5 (1·21%) | 1943·4 (0·10%) |
| Endocrine, metabolic, blood, and immune disorders | 49 928·4 (2·73%) | 49 327·8 (2·55%) | 1549·8 (2·50%) | 1376·0 (2·24%) | 27 203·1 (1·41%) | 20 280·1 (1·05%) | 1844·7 (0·10%) |
| Sickle cell trait | 29 862·3 (1·63%) | 43 353·9 (2·24%) | 1003·5 (1·62%) | 1396·6 (2·27%) | 20 041·4 (1·04%) | 21 564·0 (1·12%) | 1748·5 (0·09%) |
| Uterine fibroids | 28 043·2 (1·53%) | 36 833·7 (1·91%) | 1106·6 (1·78%) | 1304·9 (2·12%) | 21 328·2 (1·10%) | 14 540·7 (0·75%) | 964·8 (0·05%) |
| Hookworm disease | 32 039·8 (1·75%) | 34 579·6 (1·79%) | 1021·8 (1·65%) | 1004·0 (1·63%) | 18 037·6 (0·93%) | 15 308·0 (0·79%) | 1233·9 (0·06%) |
| Peptic ulcer disease | 34 671·6 (1·90%) | 32 726·7 (1·69%) | 980·6 (1·58%) | 974·6 (1·58%) | 14 995·6 (0·78%) | 16 717·0 (0·87%) | 1014·1 (0·05%) |
| Chronic kidney disease due to other causes | 16 459·1 (0·90%) | 26 007·2 (1·35%) | 857·2 (1·38%) | 1330·6 (2·16%) | 13 154·8 (0·68%) | 12 140·3 (0·63%) | 712·1 (0·04%) |
| Schistosomiasis | 14 488·1 (0·79%) | 20 635·1 (1·07%) | 485·3 (0·78%) | 671·0 (1·09%) | 9546·6 (0·49%) | 10 151·0 (0·53%) | 937·5 (0·05%) |
| Other gynaecological diseases | 15 576·9 (0·85%) | 17 383·2 (0·90%) | 462·8 (0·75%) | 448·6 (0·73%) | 9842·0 (0·51%) | 7108·8 (0·37%) | 432·4 (0·02%) |
| Chronic kidney disease due to hypertension | 10 850·3 (0·59%) | 14 142·6 (0·73%) | 587·6 (0·95%) | 733·8 (1·19%) | 7986·0 (0·41%) | 5738·2 (0·30%) | 418·5 (0·02%) |
| Chronic kidney disease due to glomerulonephritis | 11 180·9 (0·61%) | 14 059·9 (0·73%) | 613·3 (0·99%) | 745·9 (1·21%) | 6924·4 (0·36%) | 6557·2 (0·34%) | 578·3 (0·03%) |
| Chronic kidney disease due to diabetes mellitus | 6569·6 (0·36%) | 12 116·3 (0·63%) | 348·0 (0·56%) | 606·6 (0·99%) | 8024·2 (0·42%) | 3545·8 (0·18%) | 546·3 (0·03%) |
| Sickle cell disorders | 1801·5 (0·10%) | 3185·0 (0·16%) | 182·5 (0·29%) | 321·4 (0·52%) | 434·2 (0·02%) | 2176·5 (0·11%) | 574·3 (0·03%) |
| Glucose-6-phosphate dehydrogenase deficiency trait | 1253·7 (0·07%) | 1983·8 (0·10%) | 39·5 (0·06%) | 48·8 (0·08%) | 1196·4 (0·06%) | 732·9 (0·04%) | 54·5 (0·00%) |
| Maternal haemorrhage | 1388·0 (0·08%) | 1858·5 (0·10%) | 39·4 (0·06%) | 45·1 (0·07%) | 1099·8 (0·06%) | 724·4 (0·04%) | 34·4 (0·00%) |
| Glucose-6-phosphate dehydrogenase deficiency | 519·3 (0·03%) | 743·5 (0·04%) | 24·9 (0·04%) | 33·8 (0·05%) | 389·7 (0·02%) | 205·3 (0·01%) | 148·5 (0·01%) |
| Thalassaemias | 509·8 (0·03%) | 544·2 (0·03%) | 43·2 (0·07%) | 46·2 (0·08%) | 31·2 (0·00%) | 375·4 (0·02%) | 137·5 (0·01%) |
| Total prevalence | 1 828 942·2 (100·00%) | 1 931 202·6 (100·00%) | .. | .. | 950 135·2 (49·20%) | 905 501·8 (46·89%) | 75 565·6 (3·91%) |
| Total YLDs | .. | .. | 62 023·8 (100·00%) | 61 525·6 (100·00%) | 4298·6 (6·99%) | 46 287·9 (75·23%) | 10 939·1 (17·78%) |